The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Michael Hofman
Consulting or Advisory Role - Advancell (Inst); AstraZeneca (Inst); Bicycle Therapeutics; Janssen; MSD; Novartis (Inst); Sanofi
Research Funding - Bayer (Inst); Isotopia (Inst); ITM Isotope Technologies Munich (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Debiopharm Group (Inst); GE Healthcare (Inst); Novartis
 
Francoise Kraeber-Bodere
Honoraria - Immedica, Novartis, Keosys
Consulting or Advisory Role - Immedica, Novartis, Radionetics
Research Funding - Siemens, Telix Pharmaceuticals
Travel, Accommodations, Expenses - Novartis
 
Thibaut Cassou Mounat
Speakers' Bureau - Gilead Sciences
 
Hakim Mahammedi
Honoraria - AAA/Endocyte/Novartis; Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS; Curium Pharma; Eisai; Janssen-Cilag; MSD Oncology; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; BMS; Eisai; Novartis
Travel, Accommodations, Expenses - Bayer; BMS GmbH & Co. KG; Ipsen; Janssen-Cilag; Novartis; Pfizer
(OPTIONAL) Uncompensated Relationships - Curium Pharma
 
Armelle Vinceneux
Consulting or Advisory Role - AAA/Endocyte/Novartis; Ipsen; Loxo/Lilly; Pfizer
Research Funding - Astellas Pharma (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Eisai; Johnson & Johnson/Janssen; MSD Oncology; Pfizer
 
Loic Djaileb
No Relationships to Disclose
 
Darren Feldman
Consulting or Advisory Role - BioNTech; Debiopharm Group; Exelixis; Novo Nordisk (I); Shabas; Telix Pharmaceuticals; Xencor
Speakers' Bureau - Novo Nordisk (I)
Research Funding - Bristol-Myers Squibb/Roche; Exelixis; GlaxoSmithKline (I); Lilly (I); Merck (I); Telix Pharmaceuticals
Other Relationship - UpToDate
 
Pierre Olivier
No Relationships to Disclose
 
Clement Bailly
Consulting or Advisory Role - Novartis; Boston Scientific; Telix
 
Julia Jauch-Lembach
Employment - Debiopharm Group
 
Yun Qin
Employment - ITM Oncologics
Stock and Other Ownership Interests - Isotopen Technologien
 
Henry Däbritz
Employment - Bayer UK; ITM Oncologics
Stock and Other Ownership Interests - Isotopen Technologien
 
Lewis Au
Honoraria - Bristol Myers Squibb Foundation; Eisai; Ipsen; Merck Sharp & Dohme
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Sharp & Dohme
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Eisai; Ipsen; Merck Sharp & Dohme
Travel, Accommodations, Expenses - Roche/Genentech